PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20494037-8	2010	Plasma levels of MMP types associated with inflammation, MMP-8, and MMP-9, were twofold higher in the late post-CPB period in the TXA group when compared with the aprotinin group.	Tranexamic Acid	130-133	matrix metallopeptidase 9	Homo sapiens	68-73	
34627673-10	2022	MMP-9 was elevated in the placebo group early postoperatively and in the TXA group at the immediate postoperative time point and after 24 hours.	Tranexamic Acid	73-76	matrix metallopeptidase 9	Homo sapiens	0-5	
23261456-6	2013	Furthermore, injection of tranexamic acid, a plasmin inhibitor, more markedly reduced MMP-9 and MMP-2 activity and angiogenesis in tumors originating from progalanin siRNA-treated SBC-3A cells and in tumor tissue originating from progalanin siRNA-treated SBC-3A cells in the presence of progalanin.	Tranexamic Acid	26-41	matrix metallopeptidase 9	Homo sapiens	86-91	
23261456-7	2013	The reduction of MMP-9 and MMP-2 activity with tranexamic acid was restored by galanin, but not by progalanin.	Tranexamic Acid	47-62	matrix metallopeptidase 9	Homo sapiens	17-22